Who are the key players involved in the respiratory syncytial virus treatment market?

GlaxoSmithKline (GSK)
Pfizer
AstraZeneca / Sanofi (collaboration)
Moderna
Novavax
Merck & Co
AbbVie, Gilead, Roche